Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2013Dementia and Geriatric Cognitive Disorders

Validation of the Addenbrooke's Cognitive Examination III in Frontotemporal Dementia and Alzheimer's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSharpley HsiehThe University of QueenslandSSSamantha SchubertThe University of SydneyCHChristopher HoonNeuroscience Research Australia

Discussion

Loading...

Member takes

Implication

Validation study demonstrates the utility of the ACE-III for detecting cognitive deficits in frontotemporal dementia and Alzheimer's disease, highlighting its value as an objective screening tool.

Key Points

  • To provide objective clinical validation for the Addenbrooke's Cognitive Examination III (ACE-III) as a diagnostic screening instrument for cognitive deficits in frontotemporal dementia and Alzheimer's disease.
  • Evaluated the diagnostic utility of the Addenbrooke's Cognitive Examination III (ACE-III) as a screening instrument in cohorts with frontotemporal dementia and Alzheimer's disease.
  • Demonstrated objective validation of the ACE-III for detecting cognitive deficits across frontotemporal dementia and Alzheimer's disease.

Cite This Study

Hsieh et al. (2013) studied this question.

synapsesocial.com/papers/69dc5d084f901957bec10404https://doi.org/10.1159/000351671
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Serial Sevens Versus World Backwards: A Comparison of the Two Measures of Attention From the MMSE1990 · 62 citations
  2. 2The Rowland Universal Dementia Assessment Scale (RUDAS) and the Folstein MMSE in a multicultural cohort of elderly persons2006 · 117 citations
  3. 3The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening2006 · 2,062 citations
  4. 4The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: A comparative neuropsychological study.1999 · 297 citations
  5. 5The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment2005 · 26,347 citations